Chen M F, Jan Y Y, Jeng L B, Hwang T L, Wang C S, Chen S C
Department of Surgery, Chang Gung College of Medicine and Technology, Taipei, Taiwan.
Cancer. 1994 Mar 1;73(5):1335-40. doi: 10.1002/1097-0142(19940301)73:5<1335::aid-cncr2820730505>3.0.co;2-m.
Hepatocellular carcinoma (HCC) presenting as obstructive jaundice caused by floating tumor debris in common bile duct is rare. Taiwan has a high incidence of HCC and cirrhosis. The authors report their clinical experiences and evaluate the results of different treatment modalities for this disease.
A retrospective study was undertaken to review 20 patients with obstructive jaundice secondary to ruptured HCC into common bile duct during the 12 years period.
All patients on initial examination had recurrent episodic jaundice or cholangitis. Jaundice was relieved by nonsurgical, percutaneous transhepatic biliary stenting in 4 patients and surgical intubation with T-tube drainage in 16. Types of treatment for those who were treated nonsurgically were percutaneous transhepatic biliary stenting in two patients, followed by transcatheter hepatic arterial embolization in another two patients. For the 16 patients who were treated surgically, the types of treatment were T-tube or Y-tube drainage in 11, T-tube drainage followed by hepatic resection in 2, T-tube drainage and hepatic arterial ligation in 1, and T-tube drainage followed by transcatheter hepatic arterial embolization in the other 2. Liver cirrhosis was the associated disease in 12 (75%). Four patients (20%) died in the hospital. The mean survival time for 12 patients with only surgical or nonsurgical biliary stenting was 3.9 months. For the three patients with percutaneous hepatic arterial embolization, the mean survival time was 8.0 months. Two patients who had undergone hepatic resection had a better postoperative survival time, with one surviving for more than 5 years.
Clinical features, types of management, operative findings, and survival in 20 patients with HCC obstructing the common bile duct by tumor thrombi were reviewed. Not all patients with this disease were terminally ill. With proper management, good palliation and occasional cure are possible.
肝细胞癌(HCC)表现为因胆总管内漂浮肿瘤碎片导致的梗阻性黄疸较为罕见。台湾地区HCC和肝硬化的发病率较高。作者报告了他们的临床经验,并评估了针对该疾病不同治疗方式的结果。
进行一项回顾性研究,以回顾12年间20例因HCC破裂进入胆总管继发梗阻性黄疸的患者。
所有患者初诊时均有反复发作的黄疸或胆管炎。4例患者通过非手术的经皮肝穿刺胆道支架置入术黄疸得到缓解,16例通过手术置入T管引流缓解。非手术治疗的患者中,2例行经皮肝穿刺胆道支架置入术,另2例随后行肝动脉化疗栓塞术。16例接受手术治疗的患者中,11例行T管或Y管引流,2例行T管引流后肝切除术,1例行T管引流和肝动脉结扎术,另2例行T管引流后肝动脉化疗栓塞术。12例(75%)患者合并肝硬化。4例(20%)患者在医院死亡。仅接受手术或非手术胆道支架置入术的12例患者的平均生存时间为3.9个月。3例行经皮肝动脉化疗栓塞术的患者平均生存时间为8.0个月。2例行肝切除术的患者术后生存时间较好,其中1例存活超过5年。
回顾了20例因肿瘤血栓阻塞胆总管的HCC患者的临床特征、治疗方式、手术发现和生存情况。并非所有该疾病患者均为晚期。通过适当的管理,有可能实现良好的姑息治疗并偶尔治愈。